Targeting inflammation and cytokine storm in COVID-19.Pharmacol Res. 2020 Sep; 159:105051.PR
Links
MeSH
Anti-Inflammatory AgentsBetacoronavirusCOVID-19Cell Cycle ProteinsCoronavirus InfectionsCytokinesHost Microbial InteractionsHumansImmunologic FactorsInflammasomesInflammationInterleukin-6Models, ImmunologicalNLR Family, Pyrin Domain-Containing 3 ProteinPandemicsPneumonia, ViralSARS-CoV-2Transcription FactorsCOVID-19 Drug Treatment
Pub Type(s)
Journal Article
Language
eng
PubMed ID
32603772
Citation
Huang, Qianwen, et al. "Targeting Inflammation and Cytokine Storm in COVID-19." Pharmacological Research, vol. 159, 2020, p. 105051.
Huang Q, Wu X, Zheng X, et al. Targeting inflammation and cytokine storm in COVID-19. Pharmacol Res. 2020;159:105051.
Huang, Q., Wu, X., Zheng, X., Luo, S., Xu, S., & Weng, J. (2020). Targeting inflammation and cytokine storm in COVID-19. Pharmacological Research, 159, 105051. https://doi.org/10.1016/j.phrs.2020.105051
Huang Q, et al. Targeting Inflammation and Cytokine Storm in COVID-19. Pharmacol Res. 2020;159:105051. PubMed PMID: 32603772.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Targeting inflammation and cytokine storm in COVID-19.
AU - Huang,Qianwen,
AU - Wu,Xiumei,
AU - Zheng,Xueying,
AU - Luo,Sihui,
AU - Xu,Suowen,
AU - Weng,Jianping,
Y1 - 2020/06/27/
PY - 2020/6/24/received
PY - 2020/6/25/accepted
PY - 2020/7/1/pubmed
PY - 2020/9/12/medline
PY - 2020/7/1/entrez
SP - 105051
EP - 105051
JF - Pharmacological research
JO - Pharmacol Res
VL - 159
SN - 1096-1186
UR - https://www.unboundmedicine.com/medline/citation/32603772/Targeting_inflammation_and_cytokine_storm_in_COVID_19_
DB - PRIME
DP - Unbound Medicine
ER -